FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

15973311000001105: Metformin 500mg tablets (Zanza Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56454401000001113 Metformin 500mg tablets (Zanza Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110022201000001119 Metformin 500mg tablets (Zanza Specials International Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metformin 500mg tablets (Zanza Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Is a Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has active ingredient Metformin hydrochloride false Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Metformin 500mg tablets (Zanza Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Metformin 500mg tablets (Zanza Laboratories Ltd) Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) 84 tablet 6 x 14 tablets Has AMP True Metformin 500mg tablets (Zanza Laboratories Ltd) Inferred relationship Existential restriction modifier
Metformin 500mg tablets (Zanza Laboratories Ltd) 500 tablet Has AMP True Metformin 500mg tablets (Zanza Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start